Browse
We’re here to help

Find guidance on Author Services

Login | Register

Login
Register

Cart Add to Cart

Search
Browse
We’re here to help

Find guidance on Author Services

Home
All Journals
Expert Opinion on Therapeutic Targets
List of Issues
Volume 28, Issue 1-2

Expert Opinion on Therapeutic Targets

Search in:

Advanced search Citation search

Citation search

Ready to submit?
Start a new submission or continue a submission in progress
Go to submission site
Instructions for authors
Editorial policies
Editing services site

Journal metrics
Aims & scope
Journal information
Editorial board
News & calls for papers
Advertising information

Latest articles
Current issue
All volumes & issues
Special issues
Open access articles
Most read articles
Most cited articles

New content alerts
RSS

Subscription options & pricing

Buy a subscription

Your download is now in progress and you may close this window

Did you know that with a free Taylor & Francis Online account you can gain access to the following benefits?

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Have an account?
Login now Don't have an account?
Register for free

Login or register to access this feature

Have an account?
Login now Don't have an account?
Register for free

Register a free Taylor & Francis Online account today to boost your research and gain these benefits:

Choose new content alerts to be informed about new research of interest to you
Easy remote access to your institution's subscriptions on any device, from any location
Save your searches and schedule alerts to send you new results
Export your search results into a .csv file to support your research

Register now or learn more

Expert Opinion on Therapeutic Targets, Volume 28, Issue 1-2 (2024)

Browse this journal

Latest articles
Current issue
List of issues
Special issues
Open access articles
Most read articles
Most cited articles

Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Opinion on Therapeutic Targets, Volume 28, Issue 1-2 (2024)

See all volumes and issues

Volume 28, 2024 Vol 27, 2023 Vol 26, 2022 Vol 25, 2021 Vol 24, 2020 Vol 23, 2019 Vol 22, 2018 Vol 21, 2017 Vol 20, 2016 Vol 19, 2015 Vol 18, 2014 Vol 17, 2013 Vol 16, 2012 Vol 15, 2011 Vol 14, 2010 Vol 13, 2009 Vol 12, 2008 Vol 11, 2007 Vol 10, 2006 Vol 9, 2005 Vol 8, 2004 Vol 7, 2003 Vol 6, 2002 Vol 5, 2001 Vol 5, 2001 Vol 4, 2000 Vol 3, 1999 Vol 2, 1998 Vol 1, 1997

Select to download all citations or PDFs

Download citations Download PDFs Download issue

Browse by section (All)

Display order (Default)
Published online date
Page number
Section A-Z
Most read
Most cited

Editorial

Mitochondrial permeability transition pore: a snapshot of a therapeutic target

Mario Zoratti, Lucia Biasutto, Sofia Parrasia & Ildikó Szabo

Pages: 1-3

Published online: 19 Jan 2024

First Page PreviewforMitochondrial permeability transition pore: a snapshot of a therapeutic target | Full Text | References | PDF (163 KB) | EPUB

697 Views
0 CrossRef citations
0Altmetric

Free Access

Editorial

Role of the P2Y12 receptor on thrombus formation and evolution in therapeutic strategies

Mattia Galli & Dominick J. Angiolillo

Pages: 5-8

Published online: 06 Feb 2024

First Page PreviewforRole of the P2Y12 receptor on thrombus formation and evolution in therapeutic strategies | Full Text | References | PDF (788.1 KB) | EPUB

503 Views
0 CrossRef citations
0Altmetric

Free Access

Special Report

Report

Powering down the mitochondrial LonP1 protease: a novel strategy for anticancer therapeutics

Rahul Shetty, Roberto Noland, Ghata Nandi & Carolyn K. Suzuki

Pages: 9-15

Published online: 29 Dec 2023

AbstractforPowering down the mitochondrial LonP1 protease: a novel strategy for anticancer therapeutics | Full Text | References | PDF (1.3 MB) | EPUB

1152 Views
0 CrossRef citations
0Altmetric

Open Access

Review

Review Article

Epigenetic determinants in soft tissue sarcomas: molecular mechanisms and therapeutic targets

Alessandra Merlini, Martina Rabino, Silvia Brusco, Valeria Pavese, Debora Masci, Dario Sangiolo, Paolo Bironzo, Giorgio Vittorio Scagliotti, Silvia Novello & Lorenzo D’Ambrosio

Pages: 17-28

Published online: 26 Jan 2024

AbstractforEpigenetic determinants in soft tissue sarcomas: molecular mechanisms and therapeutic targets | Full Text | References | PDF (2.3 MB) | EPUB

136 Views
0 CrossRef citations
0Altmetric

Review Article

New therapeutic targets for endometrial cancer: a glimpse into the preclinical sphere

Ilan Bruchim, Ilaria Capasso, Ariel Polonsky, Shilhav Meisel, Vanda Salutari, Haim Werner, Domenica Lorusso, Giovanni Scambia & Francesco Fanfani

Pages: 29-43

Published online: 12 Feb 2024

AbstractforNew therapeutic targets for endometrial cancer: a glimpse into the preclinical sphere | Full Text | References | PDF (1.9 MB) | EPUB

189 Views
0 CrossRef citations
0Altmetric

Review Article

TGF-β as a therapeutic target in the infarcted and failing heart: cellular mechanisms, challenges, and opportunities

Nikolaos G. Frangogiannis

Pages: 45-56

Published online: 19 Feb 2024

AbstractforTGF-β as a therapeutic target in the infarcted and failing heart: cellular mechanisms, challenges, and opportunities | Full Text | References | PDF (4.3 MB) | EPUB

246 Views
0 CrossRef citations
0Altmetric

Review Article

Cytokines of the interleukin-6 family as emerging targets in inflammatory bowel disease

Christoph Garbers & Juliane Lokau

Pages: 57-65

Published online: 23 Jan 2024

AbstractforCytokines of the interleukin-6 family as emerging targets in inflammatory bowel disease | Full Text | References | PDF (1.1 MB) | EPUB

252 Views
0 CrossRef citations
0Altmetric

Review Article

Kv1.3 in the spotlight for treating immune diseases

María Navarro-Pérez, Jesusa Capera, Anna Benavente-Garcia, Silvia Cassinelli, Magalí Colomer-Molera & Antonio Felipe

Pages: 67-82

Published online: 07 Feb 2024

AbstractforKv1.3 in the spotlight for treating immune diseases | Full Text | References | PDF (1.6 MB) | EPUB

190 Views
0 CrossRef citations
0Altmetric

Original Research

Article

Myricetin, a natural inhibitor of CD147, increases sensitivity of cisplatin in ovarian cancer

Lin Chen, Tian Fan, Miao Wang, Chun-Yu Zhu, Wang-You Feng, Yu Li & Hong Yang

Pages: 83-95

Published online: 23 Jan 2024

951 Views
0 CrossRef citations
0Altmetric

Open Access

Article

Tumor cells-derived extracellular vesicles carry circ_0064516 competitively inhibit microRNA-6805-3p and promote cervical cancer angiogenesis and tumor growth

Yujue Wang, Yao Xie, Xue Wang, Nian Yang, Zhao Wu & Xun Zhang

Pages: 97-112

Published online: 11 Mar 2024

63 Views
0 CrossRef citations
0Altmetric

Explore articles

Latest
Open access
Most read
Most cited
Trending

Explore the most recently published articles

Targeting inflammasome complexes as a novel therapeutic strategy for mood disorders

Aline Silva de Miranda et al.

Review Article | Published online: 13 Jun 2024

Fatty liver disease: time to target CCR5?

Vlad Dumitru Brata et al.

Editorial | Published online: 13 Jun 2024

Free Access

Targeting HIF-1α in sickle cell disease and cancer: unravelling therapeutic opportunities and risks.

Saba Ubaid et al.

Review Article | Published online: 11 Jun 2024

Novel benzimidazole angiotensin receptor blockers with anti-SARS-CoV-2 activity equipotent to that of nirmatrelvir: computational and enzymatic studies

Harry Ridgway et al.

Article | Published online: 7 Jun 2024

View all latest articles

Download citations

Choose format

RIS (ProCit, Reference Manager)
BibTeX
RefWorks Direct Export

Download citations

Expert Opinion on Therapeutic Targets (Vol.28, Iss.1-2, 2024)

Access Rights

Only articles that you have access rights to view will be downloaded. The green tick (full access) and orange padlock (open access) icons indicate that you have full access.

Do you want to proceed?